CXCL16 expression was not statistically significantly higher in the T2DM group compared to the disease-free groups (p > 0.05), and metformin treatment increased CXCL16 expression to a statistically significant level (p < 0.05, Figure 4). This evidence concerns the gene CXCL16 and type 2 diabetes mellitus.